NCT03065075View on ClinicalTrials.gov

Effect of Phenazopyridine on Prolapse Surgery Voiding Trials

PHASE3CompletedINTERVENTIONAL
Enrollment

152

Participants

Timeline

Start Date

February 1, 2017

Primary Completion Date

August 28, 2018

Study Completion Date

February 28, 2019

Conditions
Urinary Retention Postoperative
Interventions
DRUG

Phenazopyridine

Phenazopyridine 200 mg on morning of postoperative day 1

Trial Locations (1)

01605

University of Massachusetts, Worcester

All Listed Sponsors
lead

University of Massachusetts, Worcester

OTHER

NCT03065075 - Effect of Phenazopyridine on Prolapse Surgery Voiding Trials | Biotech Hunter | Biotech Hunter